Patent · US Active

Continuous evolution for stabilized proteins

US11624130B2 · kind B2 · utility

5Cited by
40References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 18, 2018
Grant dateApr 11, 2023
Priority date
Expiry dateOct 26, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/70
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Some aspects of this disclosure relate to systems, apparatuses, compositions (e.g., isolated nucleic acids and vectors), and methods for improving the stability and/or solubility of proteins evolved using phage-assisted continuous evolution (PACE). In some embodiments, vectors described herein comprise nucleic acids encoding selection systems (e.g., positive and/or negative selection systems) that link expression of genes required for production of infectious phage particles to a desirable physiochemical (e.g., stability or solubility) and/or desired function of an evolved protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.